Literature DB >> 11120696

Sympathetic activation by sildenafil.

B G Phillips1, M Kato, C A Pesek, M Winnicki, K Narkiewicz, D Davison, V K Somers.   

Abstract

BACKGROUND: Sildenafil citrate is an effective and widely prescribed therapy for erectile dysfunction. Little is known about the effects of sildenafil on neural control of the circulation or about the effects of sildenafil on neurocirculatory stress responses. METHODS AND
RESULTS: We studied 14 normal volunteers (age 32+/-7 years) who were randomized in a double-blind crossover fashion to receive a single oral dose of sildenafil 100 mg or placebo on 2 separate study days. Blood pressure, heart rate, forearm vascular resistance, muscle sympathetic nerve activity, and plasma catecholamines were measured at baseline and at 30 and 60 minutes after sildenafil and after placebo administration. The effects of sildenafil and placebo on neural and circulatory responses to stressful stimuli (sustained handgrip, maximal forearm ischemia, mental stress, and the cold pressor test) were also evaluated. Blood pressure, heart rate, and forearm vascular resistance after sildenafil and placebo were similar. However, muscle sympathetic nerve activity increased strikingly after sildenafil (by 141+/-26%, mean+/-SEM) compared with placebo (3+/-8%) (P=0.006); plasma norepinephrine levels also increased by 31+/-5% after sildenafil administration (P=0.004). Sympathetic nerve traffic during mental, physical, and cold stresses was 2- to 8-fold higher after sildenafil than with placebo (P<0.05).
CONCLUSIONS: Sildenafil causes a marked increase in sympathetic activation, evident both at rest and during stressful stimuli. Sympathetic activation by sildenafil may have implications for understanding cardiovascular events associated with sildenafil use.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11120696     DOI: 10.1161/01.cir.102.25.3068

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  17 in total

Review 1.  Sympathoneural and adrenomedullary responses to mental stress.

Authors:  Jason R Carter; David S Goldstein
Journal:  Compr Physiol       Date:  2015-01       Impact factor: 9.090

2.  Potentiation of the NO-cGMP pathway and blood flow responses during dynamic exercise in healthy humans.

Authors:  Jacqueline K Limberg; Katherine R Malterer; J Mikhail Kellawan; William G Schrage; Brad W Wilkins; Wayne T Nicholson; John H Eisenach; Michael J Joyner; Timothy B Curry
Journal:  Eur J Appl Physiol       Date:  2016-12-24       Impact factor: 3.078

3.  Effects of epoprostenol and sildenafil on right ventricular function in hypoxic volunteers: a tissue Doppler imaging study.

Authors:  Adriana Pavelescu; Robert Naeije
Journal:  Eur J Appl Physiol       Date:  2011-07-23       Impact factor: 3.078

4.  Sildenafil citrate does not alter ventricular repolarization properties: novel evidence from dynamic QT analysis.

Authors:  Dayimi Kaya; Cem Guler; Ali Metin Esen; Irfan Barutcu; Cetin Dincel
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-07       Impact factor: 1.468

5.  Haemodynamic effects of the selective phosphodiesterase 5 inhibitor, UK-357,903, in conscious SHR.

Authors:  Sheila M Gardiner; Julie E March; Philip A Kemp; Stephen A Ballard; Ed Hawkeswood; Bernadette Hughes; Terence Bennett
Journal:  Br J Pharmacol       Date:  2003-12-08       Impact factor: 8.739

6.  Sildenafil increases sympathetically mediated vascular tone in humans.

Authors:  John M Dopp; Alexei V Agapitov; Christine A Sinkey; William G Haynes; Bradley G Phillips
Journal:  Am J Hypertens       Date:  2013-02-26       Impact factor: 2.689

Review 7.  Sildenafil and phosphodiesterase-5 inhibitors for heart failure.

Authors:  Marco Guazzi
Journal:  Curr Heart Fail Rep       Date:  2008-06

Review 8.  Phosphodiesterase 5 inhibition in heart failure: mechanisms and clinical implications.

Authors:  Praneet Kumar; Gary S Francis; W H Wilson Tang
Journal:  Nat Rev Cardiol       Date:  2009-05       Impact factor: 32.419

Review 9.  Pivotal effects of phosphodiesterase inhibitors on myocyte contractility and viability in normal and ischemic hearts.

Authors:  Yuan James Rao; Lei Xi
Journal:  Acta Pharmacol Sin       Date:  2008-12-08       Impact factor: 6.150

Review 10.  The role of the NO axis and its therapeutic implications in pulmonary arterial hypertension.

Authors:  Evangelos D Michelakis
Journal:  Heart Fail Rev       Date:  2003-01       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.